An object of the present invention is to provide a method for producing a saccharide polycondensate which is inexpensive and is applicable to a food or beverage product. Disclosed is a method for producing a saccharide polycondensate, which comprises carrying out a saccharide polycondensation reaction in the presence of activated carbon.

An object of the present invention is to provide a method for producing a saccharide polycondensate which is inexpensive and is applicable to a food or beverage product. Disclosed is a method for producing a saccharide polycondensate, which comprises carrying out a saccharide polycondensation reaction in the presence of activated carbon.

The invention relates to a novel glucose polymer which is particularly useful for administration by the parenteral route, and to the method for the production thereof. The invention also relates to compositions comprising such a glucose polymer, and to the methods for the production thereof. The invention further relates to the use thereof as a medicament, for example as an osmotic agent for peritoneal dialysis.

The invention relates to a novel glucose polymer which is particularly useful for administration by the parenteral route, and to the method for the production thereof. The invention also relates to compositions comprising such a glucose polymer, and to the methods for the production thereof. The invention further relates to the use thereof as a medicament, for example as an osmotic agent for peritoneal dialysis.

A saccharide-containing solution is prepared from a cellulosic biomass feedstock in a process, where the cellulosic biomass feedstock includes torrefied biomass material, and where the torrefied biomass material is hydrolyzed in an aqueous reactant by contacting it with the aqueous reactant that comprises hydrochloric acid with a concentration of 35 to 45% wt, based on the weight of the combination of hydrochloric acid and water, to yield a saccharide-containing solution.

The present application discloses an immunogenic composition comprising N. meningitidis capsular polysaccharides from at least one of serogroups A, C, W135 and Y conjugated to a carrier protein to produce a N. meningitidis capsular polysaccharide conjugate, wherein the average size of each N. meningitidis polysaccharide is above 50 kDa.

The present application discloses an immunogenic composition comprising N. meningitidis capsular polysaccharides from at least one of serogroups A, C, W135 and Y conjugated to a carrier protein to produce a N. meningitidis capsular polysaccharide conjugate, wherein the average size of each N. meningitidis polysaccharide is above 50 kDa.

The present invention relates to a method for preparing psicose by effectively utilizing a psicose crystallization mother liquor obtained in a psicose crystallization process, and specifically, relates to a method of preparation of psicose by putting a psicose crystallization mother liquor obtained in a psicose crystallization process into one or more kinds of processes selected from the group consisting of activated carbon treatment, ion purification process, simulated moving bed chromatography separation process and concentration process of psicose fraction to recycle.

A method has now been found for the preparation of calcium, magnesium, and zinc salts of sugar acids, this being the object of the present invention, which is characterized in that the method may include providing a sugar and oxidizing the sugar to a sugar acid in the presence of a noble metal catalyst, oxygen, and a heterogeneous hydroxide source. Preferably the oxidation is carried out with a gold catalyst, and a heterogeneous source of magnesium, calcium, or zinc hydroxide. The oxidation can be performed in a batch or continuous manner.

A method of processing an aqueous solution, wherein the aqueous solution comprises one or more dissolved sugar, one or more dissolved sugar alcohol, or a mixture thereof, wherein the method comprises bringing the aqueous solution into contact with a collection of resin beads, wherein the resin beads comprise functional groups of structure (S1).